ONCUSP THERAPEUTICS
Live / Applied — Fifth extension granted (statement of use) (as of 18 Aug 2025)
What this means for you
Not registered yet, but its 11 Jun 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90769580
- Mark type
- Design + words
- Filed
- 11 Jun 2021
- Published for opposition
- 03 Jan 2023
- Attorney of record
- Kerri E. Howard
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer
Owner
- OnCusp Therapeutics, Inc., Princeton, NJ, US
- OnCusp Therapeutics, Inc., New York, NY, US
Prosecution history
- 18 Aug 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Aug 2025 — SOU EXTENSION 5 GRANTED
- 03 Aug 2025 — SOU EXTENSION 5 FILED
- 04 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Feb 2025 — SOU EXTENSION 4 GRANTED
- 17 Feb 2025 — SOU EXTENSION 4 FILED
- 17 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 11 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Oct 2024 — SOU EXTENSION 3 GRANTED
- 28 Aug 2024 — SOU EXTENSION 3 FILED
- 08 Oct 2024 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 08 Oct 2024 — NOTICE OF REVIVAL - E-MAILED
- 08 Oct 2024 — PETITION TO REVIVE-GRANTED
- 08 Oct 2024 — TEAS PETITION TO REVIVE RECEIVED